Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Elevation of CD4+ differentiated memory T cells is associated with acute cellular and antibody-mediated rejection after liver transplantation.

Gerlach UA, Vogt K, Schlickeiser S, Meisel C, Streitz M, Kunkel D, Appelt C, Ahrlich S, Lachmann N, Neuhaus P, Pascher A, Sawitzki B.

Transplantation. 2013 Jun 27;95(12):1512-20. doi: 10.1097/TP.0b013e318290de18. Erratum in: Transplantation. 2013 Aug 27;96(4):e33.

PMID:
23619734
[PubMed - indexed for MEDLINE]
2.

Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation.

Macedo C, Walters JT, Orkis EA, Isse K, Elinoff BD, Fedorek SP, McMichael JM, Chalasani G, Randhawa P, Demetris AJ, Zeevi A, Tan H, Shapiro R, Landsittel D, Lakkis FG, Metes D.

Transplantation. 2012 Apr 27;93(8):813-21. doi: 10.1097/TP.0b013e318247a717.

PMID:
22343334
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Terminally differentiated CD8+ Temra cells are associated with the risk for acute kidney allograft rejection.

Betjes MG, Meijers RW, de Wit EA, Weimar W, Litjens NH.

Transplantation. 2012 Jul 15;94(1):63-9. doi: 10.1097/TP.0b013e31825306ff.

PMID:
22691956
[PubMed - indexed for MEDLINE]
4.

Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.

Krystufkova E, Sekerkova A, Striz I, Brabcova I, Girmanova E, Viklicky O.

Nephrol Dial Transplant. 2012 Jun;27(6):2576-82. doi: 10.1093/ndt/gfr693. Epub 2011 Dec 13.

PMID:
22167587
[PubMed - indexed for MEDLINE]
Free Article
5.

Intrahepatic proliferation of 'naive' and 'memory' T cells during liver allograft rejection: primary immune response within the allograft.

Dollinger MM, Howie SE, Plevris JN, Graham AM, Hayes PC, Harrison DJ.

FASEB J. 1998 Aug;12(11):939-47.

PMID:
9707166
[PubMed - indexed for MEDLINE]
Free Article
6.

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial.

Neuhaus P, Clavien PA, Kittur D, Salizzoni M, Rimola A, Abeywickrama K, Ortmann E, Chodoff L, Hall M, Korn A, Nashan B; CHIC 304 International Liver Study Group.

Liver Transpl. 2002 Feb;8(2):132-42.

PMID:
11862589
[PubMed - indexed for MEDLINE]
Free Article
7.

Basiliximab as therapy for acute rejection after liver transplantation for hepatitis C virus cirrhosis.

Togashi J, Sugawara Y, Tamura S, Kaneko J, Yamashiki N, Aoki T, Hasegawa K, Kokudo N.

Biosci Trends. 2011;5(2):57-60.

PMID:
21572248
[PubMed - indexed for MEDLINE]
Free Article
8.

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP.

Lancet. 1997 Oct 25;350(9086):1193-8. Erratum in: Lancet 1997 Nov 15;350(9089):1484.

PMID:
9652559
[PubMed - indexed for MEDLINE]
9.

Treatment of steroid-resistant acute liver transplant rejection with basiliximab.

Fernandes ML, Lee YM, Sutedja D, Wai CT, Isacc J, Prabhakaran K, Lim SG, Lee KH.

Transplant Proc. 2005 Jun;37(5):2179-80.

PMID:
15964372
[PubMed - indexed for MEDLINE]
11.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

PMID:
15899149
[PubMed - indexed for MEDLINE]
Free Article
12.

Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation.

Orr DW, Portmann BC, Knisely AS, Stoll S, Rela M, Muiesan P, Bowles MJ, Heaton ND, O'Grady JG, Heneghan MA.

Transplant Proc. 2005 Dec;37(10):4373-9.

PMID:
16387124
[PubMed - indexed for MEDLINE]
13.

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D; Thymoglobulin Induction Study Group.

N Engl J Med. 2006 Nov 9;355(19):1967-77.

PMID:
17093248
[PubMed - indexed for MEDLINE]
Free Article
14.

Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.

Calmus Y, Scheele JR, Gonzalez-Pinto I, Jaurrieta EJ, Klar E, Pageaux GP, Scudamore CH, Cuervas-Mons V, Metselaar HJ, Prestele H, Girault D.

Liver Transpl. 2002 Feb;8(2):123-31.

PMID:
11862588
[PubMed - indexed for MEDLINE]
Free Article
15.

Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.

Kim EY, Lee EN, Lee J, Park HJ, Chang CY, Jung da Y, Choi SY, Lee SK, Joh JW, Kim SJ.

Exp Mol Med. 2006 Jun 30;38(3):284-94.

PMID:
16819287
[PubMed - indexed for MEDLINE]
Free Article
16.

Basiliximab induction in adult liver transplant recipients with 93% rejection-free patient and graft survival at 24 months.

Ramirez CB, Doria C, di Francesco F, Iaria M, Kang Y, Marino IR.

Transplant Proc. 2006 Dec;38(10):3633-5. Erratum in: Transplant Proc. 2007 Apr;39(3):779. DiFrancesco, F [corrected to di Francesco, F].

PMID:
17175352
[PubMed - indexed for MEDLINE]
17.

Liver allograft rejection in rats depleted of CD8+ cells.

Ninova DI, Ferguson DM, Wettstein PJ, Krom RA.

Transpl Int. 1996;9(5):499-505.

PMID:
8875794
[PubMed - indexed for MEDLINE]
18.

Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.

Carrier M, Leblanc MH, Perrault LP, White M, Doyle D, Beaudoin D, Guertin MC.

J Heart Lung Transplant. 2007 Mar;26(3):258-63.

PMID:
17346628
[PubMed - indexed for MEDLINE]
19.

Role of CD4+ and CD8+ T cells in early and late acute rejection of small bowel allograft.

Guo WH, Tian L, Chan KL, Dallman M, Tam PK.

J Pediatr Surg. 2001 Feb;36(2):352-6. Erratum in: J Pediatr Surg 2001 Oct;36(10):1608.

PMID:
11172433
[PubMed - indexed for MEDLINE]
20.

Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.

Orosz CG, Wakely E, Sedmak DD, Bergese SD, VanBuskirk AM.

Transplantation. 1997 Apr 27;63(8):1109-17.

PMID:
9133472
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk